These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 24518562

  • 21. Impact of changing from cyclosporine to tacrolimus on pharmacokinetics of mycophenolic acid in renal transplant recipients with diabetes.
    Park JM, Lake KD, Cibrik DM.
    Ther Drug Monit; 2008 Oct; 30(5):591-6. PubMed ID: 18708992
    [Abstract] [Full Text] [Related]

  • 22. The pharmacokinetics of mycophenolate mofetil in Thai kidney transplant recipients.
    Jirasiritham S, Sumethkul V, Mavichak V, Na-Bangchang K.
    Transplant Proc; 2004 Sep; 36(7):2076-8. PubMed ID: 15518751
    [Abstract] [Full Text] [Related]

  • 23. Renal graft function and low-dose cyclosporine affect mycophenolic acid pharmacokinetics in kidney transplantation.
    Cortinovis M, Gotti E, Pradini S, Gaspari F, Perico N.
    Transplantation; 2011 Sep 15; 92(5):550-6. PubMed ID: 21709602
    [Abstract] [Full Text] [Related]

  • 24. Conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium in maintenance renal transplant recipients receiving tacrolimus: clinical, pharmacokinetic, and pharmacodynamic outcomes.
    Budde K, Glander P, Krämer BK, Fischer W, Hoffmann U, Bauer S, Grohmann J, Neumayer HH, Arns W.
    Transplantation; 2007 Feb 27; 83(4):417-24. PubMed ID: 17318074
    [Abstract] [Full Text] [Related]

  • 25. Randomized trial of everolimus-facilitated calcineurin inhibitor minimization over 24 months in renal transplantation.
    Cibrik D, Silva HT, Vathsala A, Lackova E, Cornu-Artis C, Walker RG, Wang Z, Zibari GB, Shihab F, Kim YS.
    Transplantation; 2013 Apr 15; 95(7):933-42. PubMed ID: 23422495
    [Abstract] [Full Text] [Related]

  • 26. Cinacalcet's effect on the pharmacokinetics of tacrolimus, cyclosporine and mycophenolate in renal transplant recipients.
    Falck P, Vethe NT, Asberg A, Midtvedt K, Bergan S, Reubsaet JL, Holdaas H.
    Nephrol Dial Transplant; 2008 Mar 15; 23(3):1048-53. PubMed ID: 17956893
    [Abstract] [Full Text] [Related]

  • 27. Pharmacokinetics and variability of mycophenolic acid from enteric-coated mycophenolate sodium compared with mycophenolate mofetil in de novo heart transplant recipients.
    Hummel M, Yonan N, Ross H, Miller LW, Sechaud R, Balez S, Koelle EU, Gerosa G, ERL 2401 Study Group.
    Clin Transplant; 2007 Mar 15; 21(1):18-23. PubMed ID: 17302587
    [Abstract] [Full Text] [Related]

  • 28. The impact of renal allograft function on exposure and elimination of mycophenolic acid (MPA) and its metabolite MPA 7-O-glucuronide.
    Naesens M, de Loor H, Vanrenterghem Y, Kuypers DR.
    Transplantation; 2007 Aug 15; 84(3):362-73. PubMed ID: 17700162
    [Abstract] [Full Text] [Related]

  • 29. Randomized crossover study to assess the inter- and intrasubject variability of morning mycophenolic acid concentrations from enteric-coated mycophenolate sodium and mycophenolate mofetil in stable renal transplant recipients.
    Tedesco-Silva H, Felipe CR, Park SI, Pinheiro-Machado PG, Garcia R, Slade A, Schmouder R, Medina-Pestana JO.
    Clin Transplant; 2010 Aug 15; 24(4):E116-23. PubMed ID: 20047618
    [Abstract] [Full Text] [Related]

  • 30. Trough levels of mycophenolic acid and its glucuronidated metabolite in renal transplant recipients.
    Merkel U, Lindner S, Vollandt R, Sperschneider H, Balogh A.
    Int J Clin Pharmacol Ther; 2005 Aug 15; 43(8):379-88. PubMed ID: 16119513
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetics and pharmacodynamics of mycophenolic acid in stable renal transplant recipients treated with low doses of mycophenolate mofetil.
    Brunet M, Martorell J, Oppenheimer F, Vilardell J, Millán O, Carrillo M, Rojo I, Corbella J.
    Transpl Int; 2000 Aug 15; 13 Suppl 1():S301-5. PubMed ID: 11112019
    [Abstract] [Full Text] [Related]

  • 32. Evaluation of limited sampling strategies for mycophenolic acid after mycophenolate mofetil intake in adult kidney transplant recipients.
    Barraclough KA, Isbel NM, Franklin ME, Lee KJ, Taylor PJ, Campbell SB, Petchey WG, Staatz CE.
    Ther Drug Monit; 2010 Dec 15; 32(6):723-33. PubMed ID: 21068647
    [Abstract] [Full Text] [Related]

  • 33. Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus.
    Jain A, Venkataramanan R, Hamad IS, Zuckerman S, Zhang S, Lever J, Warty VS, Fung JJ.
    J Clin Pharmacol; 2001 Mar 15; 41(3):268-76. PubMed ID: 11269567
    [Abstract] [Full Text] [Related]

  • 34. Pharmacokinetics of mycophenolate mofetil in stable pediatric liver transplant recipients receiving mycophenolate mofetil and cyclosporine.
    Lobritto SJ, Rosenthal P, Bouw R, Leung M, Snell P, Mamelok RD.
    Liver Transpl; 2007 Nov 15; 13(11):1570-5. PubMed ID: 17969194
    [Abstract] [Full Text] [Related]

  • 35. Cyclosporine alters correlation between free and total mycophenolic acid in kidney transplant recipients in the initial phase.
    Mino Y, Naito T, Otsuka A, Takayama T, Ozono S, Kagawa Y, Kawakami J.
    J Clin Pharm Ther; 2011 Apr 15; 36(2):217-24. PubMed ID: 21366651
    [Abstract] [Full Text] [Related]

  • 36. Developmental changes of MPA exposure in children.
    Yoo EC, Alvarez-Elías AC, Todorova EK, Filler G.
    Pediatr Nephrol; 2016 Jun 15; 31(6):975-82. PubMed ID: 26743220
    [Abstract] [Full Text] [Related]

  • 37. Graft survival following living-donor renal transplantation: a comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroids.
    Bunnapradist S, Daswani A, Takemoto SK.
    Transplantation; 2003 Jul 15; 76(1):10-5. PubMed ID: 12865780
    [Abstract] [Full Text] [Related]

  • 38. Mycophenolate, clinical pharmacokinetics, formulations, and methods for assessing drug exposure.
    Tett SE, Saint-Marcoux F, Staatz CE, Brunet M, Vinks AA, Miura M, Marquet P, Kuypers DR, van Gelder T, Cattaneo D.
    Transplant Rev (Orlando); 2011 Apr 15; 25(2):47-57. PubMed ID: 21190834
    [Abstract] [Full Text] [Related]

  • 39. Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid.
    van Gelder T, Klupp J, Barten MJ, Christians U, Morris RE.
    Ther Drug Monit; 2001 Apr 15; 23(2):119-28. PubMed ID: 11294511
    [Abstract] [Full Text] [Related]

  • 40. Mycophenolic acid formulation affects cyclosporine pharmacokinetics in stable kidney transplant recipients.
    Cattaneo D, Merlini S, Baldelli S, Bartolini B, Nicastri A, Gotti E, Remuzzi G, Perico N.
    Ther Drug Monit; 2006 Oct 15; 28(5):643-9. PubMed ID: 17038879
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.